No drug-drug interaction between nelfinavir or indinavir and mefloquine in HIV-1-infected patients.
Schippers
E F
EF
Department of Infectious Diseases, Leiden University Medical Center, The Netherlands.
Hugen
P W
PW
den Hartigh
J
J
Burger
D M
DM
Hoetelmans
R M
RM
Visser
L G
LG
Kroon
F P
FP
D000962:Antimalarials / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D004347:Drug Interactions; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use; D006207:Half-Life; D006801:Humans; D019469:Indinavir / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use; D008288:Malaria / Q000517:prevention & control; D015767:Mefloquine / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D019888:Nelfinavir / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use
D000962:Antimalarials; D017320:HIV Protease Inhibitors; D019469:Indinavir; D019888:Nelfinavir; D015767:Mefloquine